DOCSLIB.ORG

AWARDS DINNER FRIDAY, NOVEMBER 1St the Pierre 2019 Celebrating Our Pardes Humanitarian Prizewinners and Outstanding Achievement Prizewinners WELCOME

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
AWARDS DINNER FRIDAY, NOVEMBER 1St the Pierre 2019 Celebrating Our Pardes Humanitarian Prizewinners and Outstanding Achievement Prizewinners WELCOME Brain & Behavior Research Foundation INTERNATIONAL AWARDS DINNER FRIDAY, NOVEMBER 1st The Pierre 2019 Celebrating our Pardes Humanitarian Prizewinners and Outstanding Achievement Prizewinners WELCOME Welcome to our 2019 International Awards Dinner. This year’s Pardes Humanitarian Prize in Mental Health honors Dr. William T. Carpenter, Jr., a member of the Brain & Behavior Research Foundation Scientific Council, and a BBRF prizewinner and grant recipient. Dr. Carpenter has been a transformative force in psychiatry for more than 40 years, dramatically changing how we treat schizophrenia, reduce stigma, and enhance the ethics of treatment and research. Dr. Carpenter has taken a person-centered, rather than an illness-centered view of schizophrenia which has led to more compassionate care for people with this illness. He has played a critical role in shifting the focus of treatment to the earliest stages of the illness, when interventions may have their most profound impact and maximize the likelihood of recovery. The 2019 Honorary Pardes Humanitarian Prize in Mental Health is being award- ed to Cynthia Germanotta and Born This Way Foundation for their extraordinary accomplishments and their commitment to supporting the wellness of young people and empowering them to create a kinder and braver world. Bestowed annually since 2014, the Pardes Prize recognizes a person(s) or organization whose humanitarian work is transformative and of great magnitude, changing the lives and bringing the joy of living to those facing challenges to mental health. The Prize focuses public attention on the burden of mental illness on individuals and on society, and the urgent need to expand and enhance mental health services both in the developed world and in developing countries. The Prize was named in honor of Dr. Herbert Pardes, the first recipient of the award. One of Dr. Pardes’ many contributions to our field has been his founding and continued leadership of BBRF's Scientific Council, a volunteer group of 184 mental health experts across disciplines in brain and behavior research who review all Foundation grant applications and recommend the most promising ideas to fund. Tonight nine innovative and exceptional scientists—many of them Foundation grantees— will also be honored for their contributions to the advancement of our understanding and treatment of depression, ADHD, bipolar disorder, and schizophrenia. Their work is distinguished by their use of cutting-edge technology and devotion to finding innovative new therapies that will improve our care for those living with mental illness, as well as their efforts to seek preventive and diagnostic tools for the future. Our Outstanding Achievement Prizewinners are selected by special committees of the BBRF's Scientific Council. We are delighted you are here to celebrate the progress being made in brain and behavior research. Our shared commitment to scientific advancement will change what it means to live with mental illness and will help pave the way for more people to live full, happy and productive lives. Thank you for your ongoing support. Enjoy the evening! Sincerely, Jeffrey Borenstein, M.D. President & CEO 4 Board of Directors & Dinner Committee Sponsors & Contributors 6 PARDES HUMANITARIAN PRIZE IN MENTAL HEALTH Honoree: William T. Carpenter, Jr., M.D. Honorary Tribute: Cynthia Germanotta and Born This Way Foundation 12 LIEBER PRIZE FOR OUTSTANDING ACHIEVEMENT IN SCHIZOPHRENIA RESEARCH Alan S. Brown, M.D., M.P.H. Columbia University Irving Medical Center / New York State Psychiatric Institute John J. McGrath, M.D., Ph.D. The University of Queensland / Queensland Centre for Mental Health Research 14 MALTZ PRIZE FOR INNOVATIVE & PROMISING SCHIZOPHRENIA RESEARCH Christoph Kellendonk, Ph.D. Columbia University Irving Medical Center / New York State Psychiatric Institute James P. Kesby, Ph.D. The University of Queensland 16 COLVIN PRIZE FOR OUTSTANDING ACHIEVEMENT IN MOOD DISORDERS RESEARCH Dennis S. Charney, M.D. Icahn School of Medicine at Mount Sinai Sophia Frangou, M.D., Ph.D., F.R.C.Psych Icahn School of Medicine at Mount Sinai John H. Krystal, M.D. Yale University 19 RUANE PRIZE FOR OUTSTANDING ACHIEVEMENT IN CHILD & ADOLESCENT PSYCHIATRIC RESEARCH Stephen P. Hinshaw, Ph.D. University of California, Berkeley / University of California, San Francisco 20 GOLDMAN-RAKIC PRIZE FOR OUTSTANDING ACHIEVEMENT IN COGNITIVE NEUROSCIENCE René Hen, Ph.D. Columbia University / New York State Psychiatric Institute 21 Previous Outstanding Achievement Prizewinners 31 BBRF Scientific Council BOARD OF DIRECTORS DINNER COMMITTEE President & CEO Anne and Ronald Abramson Jeffrey Borenstein, M.D. Carol Atkinson President, Janet and Donald Boardman Scientific Council Raymonde and J. Anthony Boeckh Herbert Pardes, M.D. Jeffrey Borenstein, M.D. Susan Lasker Brody, MPH Suzanne and John Golden OFFICERS Marla Press and Ken Harrison Kathy and John Hollister Chairman Stephen A. Lieber Stephen A. Lieber Carole and Harvey Mallement Vice President Tamar and Milton Maltz Anne E. Abramson Miriam E. Katowitz Léa Dartevelle and Marc R. Rappaport Secretary Virginia and Mark Silver, M.D. John B. Hollister Geoffrey A. Simon Treasurer Kenneth Sonnenfeld, Ph.D, J.D. Donald M. Boardman Barbara and John Streicker Barbara Toll DIRECTORS Frances and Robert Weisman, Esq. Carol A. Atkinson J. Anthony Boeckh Susan Lasker Brody, MPH Suzanne Golden John Kennedy Harrison II Miriam E. Katowitz Carole H. Mallement Milton Maltz Marc R. Rappaport Virginia M. Silver Geoffrey A. Simon Ken Sonnenfeld, Ph.D., J.D. Barbara K. Streicker Barbara Toll Robert Weisman, Esq. 4 SPONSORS PLATINUM BRONZE Alpine Woods Capital Investors, LLC Anne and Ronald Abramson Family Foundation Borrego Foundation, Inc. Arleen Baez Lieber Family Columbia University Graham Boeckh Foundation GOLD King & Spalding LLP Tamar and Milton Maltz SUPPORTERS BENEFACTOR INDIVIDUAL NewYork-Presbyterian Hospital Susan Lasker Brody, M.P.H. Miriam Katowitz AMBASSADOR Sandy Kazlow Janet and Donald Boardman Jeffrey Peterson Janina and Andrew Boral Mary Rossell Leslie and Michael Ross Jill and Sanford Sirulnick Sheila Scharfman and Will Socolov Amy Tisler and Jason Stipanov HONOR ROLL Pamela and James Balint VIP Daniel Klaus Born This Way Foundation Joanne Marian Clausen Family Foundation Carol Trager Beth and Robert Elliott Andrea Graham and Geoffrey Simon Shari and Louis Innamorato JSquared Press, Inc. Keysite Capital Partners Ann and Robert Laitman Marla Press and Ken Harrison Teresa and Robert Simon Barbara Streicker Janet and Myron Susin Barbara Toll Marilyn and Murry Waldman Weill Cornell Medicine 5 PARDES HUMANITARIAN PRIZE IN MENTAL HEALTH THIS INTERNATIONAL PRIZE RECOGNIZES No one has better described the goals of a physician, scientist, public citizen or orga- this international Prize than Dr. Pardes nization whose extraordinary contribution himself: “Mental illness is the largest single DR. HERBERT PARDES has made a profound impact on advancing health challenge in the world. For many the understanding of mental health and decades society has recognized major providing hope and healing for people who contributions in basic science, clinical are living with mental illness. Established research and clinical care in the non- in 2014 and awarded annually, the Pardes psychiatric health fields. The Pardes Humanitarian Prize is named in honor Humanitarian Prize has been established of Dr. Herbert Pardes, the first recipient to honor individuals who comprehensively of the award. care, teach, investigate, work, and passionately advocate for improving the The recipient of the Prize is chosen by a mental health of society, and who have distinguished international Selection had a powerful impact on reducing the Committee from nominations solicited pain inflicted by psychiatric illness.” worldwide and receives an honorarium. The Pardes Humanitarian Prize focuses public attention on the burden of mental illness on individuals and society and the urgent need to expand and enhance mental health services in the United States and globally. The Pardes Humanitarian Prize in Mental Health is sponsored in part by Janssen Research & Development, LLC, one of the Janssen Pharmaceutical Companies of Johnson & Johnson. 6 PARDES HUMANITARIAN PRIZE SELECTION COMMITTEE Herbert Pardes, M.D. Dilip V. Jeste, M.D. Executive Vice Chairman of the Board of Trustees Associate Dean for Healthy Aging and Senior Care NewYork-Presbyterian Hospital Estelle and Edgar Levi Chair in Aging Distinguished Professor of Psychiatry Celso Arango, M.D., Ph.D. and Neurosciences Head of Child and Adolescent Psychiatry Service Director, Sam and Rose Stein Institute Hospital General Universitario Gregoria for Research on Aging Maranon, Madrid University of California, San Diego Jack D. Barchas, M.D. Helen S. Mayberg, M.D. Chair, Department of Psychiatry Professor of Neurology, Neurosurgery, Weill Cornell Medical College Psychiatry and Neuroscience Psychiatrist-in-Chief NewYork-Presbyterian Hospital Director, Center of Advanced Circuit Therapeutics Icahn School of Medicine at Mount Sinai William T. Carpenter, Jr., M.D. Professor of Psychiatry and Pharmacology Vikram Patel, Ph.D., F.Med.Sci. Director, Maryland Psychiatric Research Center Professor of Global Health & Social Medicine, University of Maryland School of Medicine Department of Global and Social Medicine Harvard Medical School Judith M. Ford, Ph.D. Honorary Professor of International Mental Professor, Department of Psychiatry Health UCSF Weill Institute for Neurosciences, London
Load more

Recommended publications
  • Rediscovering the Art
    Rediscovering the art 18 Current VOL. 1, NO. 12 / DECEMBER 2002 p SYCHIATRY Current p SYCHIATRY of lithium therapy James W. Jefferson, MD s a mood stabilizer for patients with bipo- Distinguished senior scientist lar disorder, lithium was the darling of Madison Institute of Medicine, Inc. U.S. psychiatry from the 1970s to well into the 1990s. It then began an ill-deserved, gradual fall from Clinical professor of psychiatry A grace and today could be considered a pharmaceutical University of Wisconsin Medical School endangered species. But why? Did lithium lose effectiveness? Is it too toxic? Is its side effect burden too heavy? Does it interact adversely with too many medicines? Is it too cumbersome to use? Was it just a Lithium is not a fad whose time came fad whose time came and went—a psychiatric pet rock? Did it fall prey to the marketing might behind patent-protected and went. It is a valuable medication drugs? Was it replaced by more effective and safer drugs? You are partially correct if you checked “all of the that belongs in our arsenal for bipolar above,” because all contain a kernel of truth. At the same disorder. time, each is an exaggeration that does grave injustice to a remarkable medication. In addition, psychiatry appears to pay only lip service to convincing evidence that lithium is the only mood stabilizer that reduces the risk of suicide during long-term treatment.1 Some psychiatrists rationalize that “lithium is too diffi- cult to use, so I never prescribe it.”2,3 My response is simply, “try it, and I think you’ll like it.” Measuring serum lithium concentrations is simple, accurate, and inexpensive.
    [Show full text]
  • 2020 Question Book
    2020 QUESTION BOOK 13TH EDITION WHO WE ARE Welcome to the thirteenth edition of the Ninja’s Guide to PRITE! Loma Linda University Medical Center is located in sunny Southern California. about 60 miles east of Los Angeles. A part of the Adventist Health System, we provide patient care in one of the largest non-profit health systems in the nation. Loma Linda's mission is to excel in medical education, global healthcare, and community outreach, all under a central tenant: "To Make Man Whole." At the Loma Linda Department of Psychiatry, our residents are trained in many diverse patient care settings. As an official World Health Organization Collaboration Center, our department funds resident electives in Global Mental Health at locations around the world. Additionally, our residents can participate in national and international disaster relief on the LLU Behavioral Health Trauma Team. We were proud to welcome our first group of Child and Adolescent Psychiatry fellows in the Summer of 2019 and work collaboratively with 3 other residency programs within the region. Our residency didactic education is constantly evolving based upon resident feedback, and our residents have the opportunity to aid in course development. More than anything, our residency fosters an environment where residents and faculty treat each other like family. Our faculty are dedicated to resident education and professional development. We believe in "taking 'No' off the table", encouraging innovative change, and passionately supporting our residents to achieve anything they set their minds to. For over a decade our residents have volunteered their time to create The Ninja's Guide to PRITE at our Annual Ninja PRITE Workshop.
    [Show full text]
  • The Dual Effect of Lithium on Inflammatory Bowel Disease and Bipolar Disorder: a Review
    ISSN: 2638-3535 Madridge Journal of Clinical Research Review Article Open Access The Dual Effect of Lithium on Inflammatory Bowel Disease and Bipolar Disorder: A Review Gabriel DeSouza, Halford G Warlick IV, and Vincent S Gallicchio* Department of Biological Sciences, Clemson University, Clemson, South Carolina, USA Article Info Abstract *Corresponding author: Lithium has been the gold standard for treatment of bipolar disorder since the mid- Vincent S Gallicchio 20th century. Lithium, at low doses, gained popularity as the first-line treatment of this Department of Biological Sciences disorder. Eventually, lithium became part of many successful treatment plans for bipolar 122 Long Hall Clemson University and depressed patients, leading to more focused research on basic and applied Clemson, South Carolina pharmacological effects of this drug. However, the evidence that lithium can reduce USA inflammation by inhibiting glycogen synthase kinase 3 – beta (GSK3β) enzyme which is E-mail: [email protected] linked to autoimmune and inflammatory disorders, and cancer is still emerging. Therefore, this review examines whether inflammatory conditions such as Inflammatory Received: April 19, 2019 Accepted: November 27, 2019 Bowel Disease (IBD) have a higher occurrence rate of mental illness in comparison to the Published: December 6, 2019 population presenting with IBD without the co-pathology of mental illness. This investigation explored lithium’s beneficial effects in IBD when evaluated either in animal Citation: DeSouza G, Warlick IV HG, models or in IBD patients with or without chronic mental illness. Further research must Gallicchio VS. The Dual Effect of Lithium on be conducted to evaluate for significant evidence of its antipsychotic and anti- Inflammatory Bowel Disease and Bipolar Disorder: A Review.
    [Show full text]
  • Use of Antipsychotic Drugs and Lithium in Mania
    BRITISHJOURNAL OF PSYCHIATRY %20%2001), 01), 178 %suppl. 41), s14s148^ 8^ s156 Use of antipsychotic drugs and lithium in mania experience over the following 30 years indi- cated that lithium is far short of an ideal treatment, even when administered expertly JOHN COOKSON to `concordant' patients. There is a striking difference between the results of early con- trolled trials and the outcome on lithium in open clinical practice, where a smaller pro- portion of patients appear to be `lithium re- sponders'; some even doubt the validity of the clinical trials %Moncrieff, 1997). The benefits of lithium therapy have to be balanced against the difficulties in its Background Studies highlighting the Mania or a manic episode is a severe phase management ± with poor compliance in pa- difficulties associated withlithium suggest in the course of bipolar disorders, the con- tients with bipolar disorder and the occur- dition termed `manic±depressive illness' by rence of withdrawal mania ± and the risks that the role of antipsychotic drugs and Kraepelin in the 19th century. A contem- of side-effects and toxicity %Cookson, mood stabilisersin bipolardisorder should porary textbookdescribed the difficulty of 1997). The latter includes the possibility be reconsidered. managing a patient with mania ± using of permanent neurological sequelae with drugs of limited efficacy, mainly sedative cerebellar damage %Schou, 1984). Aims Toreview the efficacyandmode or anaesthetic, such as chloral and ur- Since the 1970s anticonvulsant drugs, of action of antipsychotic drugsin mania, ethane, or potentially toxic drugs, such as first carbamazepine and more recently and to consider the differences between potassium bromide. The sedative anticon- valproate and, in open studies, lamotrigine officialguidelines and routine clinical vulsant paraldehyde was also used.
    [Show full text]
  • Medicine@Yale U
    @ MedicineAdvancing Biomedical Science, Education and Health Care YaleVolume 4, Issue 3 July/August 2008 Leading scientist is appointed new chair of Cell Biology Membrane traffi c expert and chair of the School of Medicine’s to Yale’s recently protein-coding genes in the human Department of Cell Biology. Roth- opened West Cam- genome, providing fresh insights into will head a department man will come to Yale from Columbia pus in West Haven, disease and new molecular targets for that has shaped the fi eld University’s College of Physicians and Conn., where he will therapy. Under Rothman’s leadership Surgeons, where he is now a professor launch a Center for the Department of Cell Biology will James E. Rothman, F>:, one of the in the Department of Physiology and High-Throughput be signifi cantly expanded, and will be world’s foremost experts on mem- Biophysics, the Clyde and Helen Wu Cell Biology. At the co-located at the West Campus along brane traffi cking, the means by which Professor of Chemical Biology and new center, multi- with its present location at the main proteins and other materials are director of the Columbia Genome +BNFT3PUINBO disciplinary teams campus of the School of Medicine. transported within and between cells, Center. of scientists will develop tools and For his decades of seminal re- has been named the Fergus F. Wal- In addition to directing Cell techniques to rapidly decipher the cel- search on the transport of molecules lace Professor of Biomedical Sciences Biology, Rothman is the fi rst recruit lular functions of the
    [Show full text]
  • KAFUI DZIRASA, MD Phd
    KAFUI DZIRASA, MD PhD 421 Bryan Research, Box 3209 E-mail: [email protected] 311 Research Drive Durham, North Carolina 27710 Duke University Medical Center Office: (919) 681-7371 EDUCATION: University of Maryland Baltimore County, Baltimore, MD June 1996-May 2001 Bachelor of Science in Chemical Engineering, Magna cum laude Meyerhoff Scholar Duke University Graduate School, Durham NC August 2003-March 2007 Doctor of Philosophy in Neurobiology Thesis: Electrophysiological Correlates of Neurological and Psychiatric Disease Advisor: Miguel Nicolelis Postdoctoral Research August 2007-March 2009 Duke University, Durham, NC Advisor: Miguel Nicolelis Duke University School of Medicine, Durham, NC August 2001-May 2009 Doctor of Medicine Medical Scientist Training Program Duke University Hospital, Durham, NC July 2010-June 2016 Residency, General Psychiatry North Carolina Medical License License #: 2016-02599 License Status: Active EMPLOYMENT HISTORY: K. Ranga Rama Krishnan Endowed Associate Professor with Tenure, Department of Psychiatry and Behavioral Sciences. Duke University Medical Center. Aug 2019-Current K. Ranga Rama Krishnan Endowed Associate Professor, Tenure Track, Department of Psychiatry and Behavioral Sciences. Duke University Medical Center. May 2018-July 2019 Associate Professor, Tenure Track, Department of Psychiatry and Behavioral Sciences. Duke University Medical Center. September 2017-May 2018 Assistant Professor, Tenure Track, Department of Psychiatry and Behavioral Sciences. Duke University Medical Center. December 2013-August 2017 Assistant Research Professor, Department of Neurobiology. Duke University. October 2012-Current. Assistant Professor, Department of Biomedical Engineering. Duke University. March 2012-Current. Visiting Professor of Neuroscience, Edmond and Lily Safra International Institute of Neurosciences of Natal (ELS-IINN). August 2011-2019. General Psychiatry Resident, Department of Psychiatry and Behavioral Sciences.
    [Show full text]
  • A History of the Pharmacological Treatment of Bipolar Disorder
    International Journal of Molecular Sciences Review A History of the Pharmacological Treatment of Bipolar Disorder Francisco López-Muñoz 1,2,3,4,* ID , Winston W. Shen 5, Pilar D’Ocon 6, Alejandro Romero 7 ID and Cecilio Álamo 8 1 Faculty of Health Sciences, University Camilo José Cela, C/Castillo de Alarcón 49, 28692 Villanueva de la Cañada, Madrid, Spain 2 Neuropsychopharmacology Unit, Hospital 12 de Octubre Research Institute (i+12), Avda. Córdoba, s/n, 28041 Madrid, Spain 3 Portucalense Institute of Neuropsychology and Cognitive and Behavioural Neurosciences (INPP), Portucalense University, R. Dr. António Bernardino de Almeida 541, 4200-072 Porto, Portugal 4 Thematic Network for Cooperative Health Research (RETICS), Addictive Disorders Network, Health Institute Carlos III, MICINN and FEDER, 28029 Madrid, Spain 5 Departments of Psychiatry, Wan Fang Medical Center and School of Medicine, Taipei Medical University, 111 Hsin Long Road Section 3, Taipei 116, Taiwan; [email protected] 6 Department of Pharmacology, Faculty of Pharmacy, University of Valencia, Avda. Vicente Andrés, s/n, 46100 Burjassot, Valencia, Spain; [email protected] 7 Department of Pharmacology and Toxicology, Faculty of Veterinary Medicine, Complutense University, Avda. Puerta de Hierro, s/n, 28040 Madrid, Spain; [email protected] 8 Department of Biomedical Sciences (Pharmacology Area), Faculty of Medicine and Health Sciences, University of Alcalá, Crta. de Madrid-Barcelona, Km. 33,600, 28871 Alcalá de Henares, Madrid, Spain; [email protected] * Correspondence: fl[email protected] or [email protected] Received: 4 June 2018; Accepted: 13 July 2018; Published: 23 July 2018 Abstract: In this paper, the authors review the history of the pharmacological treatment of bipolar disorder, from the first nonspecific sedative agents introduced in the 19th and early 20th century, such as solanaceae alkaloids, bromides and barbiturates, to John Cade’s experiments with lithium and the beginning of the so-called “Psychopharmacological Revolution” in the 1950s.
    [Show full text]
  • Consolidated Annual Activities Report for 2014
    CONSOLIDATED ANNUAL ACTIVITIES REPORT FOR 2014 ‘The Academy of Europe’ Registered office Room 251, Senate House, Malet Street, London WC1E 7HU Tele: +44 (0) 20 7862 5784 Email: [email protected] Web: http://www.ae-info.org Company limited by Guarantee and registered at Companies House. Registration number 7028223 Registered with the Charity Commission, registration number 1133902 1 THE TRUSTEES, AND COUNCIL OF THE ACADEMIA EUROPAEA Board of TRUSTEES (at 31 December 2014) President: Professor Sierd Cloetingh Utrecht, (elected June 2014) Professor Lars Walløe Oslo (till AGM July 2014) Vice President: Professor Anne Buttimer Dublin, (till 2015 eligible for re- election) Vice President: Professor Sierd Cloetingh (till AGM 2014) Hon. Treasurer: (from January 2010) Professor Sir Roger Elliott Oxford, (till 2015) Co-opted Members: Professor Jerzy Langer Warsaw (resigned April 2014) Professor Andreu Mas Colell Barcelona (resigned June 2014) Professor Theo D’haen Leuven, (till 2015) Professor Ole Petersen Cardiff, (till 2015) Professor Hermann Maurer Graz, (till end 2015) Appointed by Council: Professor Balazs Gulyas Stockholm, (re-appointed, AGM 2013 – Dec. 2016) Professor Don Dingwell Munich, (appointed, Jan 2014, eligible for re-appointment) Professor Svend Erik Larsen Copenhagen, (appointed, Jan. 2014, eligible for re-appointment) At the time of writing this report, the number of independent members elected to Council was set at a maximum of three. The Chairs of the Academic Sections are de facto members of the Council. Periods of office of Section chairs are as described in the regulations. The list of Section chairs, as at 31 December 2014, is at annex 1a of this report. Three members of the Council are nominated to the Board of Trustees.
    [Show full text]
  • Community Clinical Learning
    EDITION 18 · JANUARY 2015 EDITION 18 · JANUARY RENews fromMED Cardiff University’s YInside… School of Medicine Newyddion o’r Ysgol Feddygaeth, Defining a standard of Prifysgol Caerdydd care for prostate cancer Live Venepuncture Community Clinical Learning DIAGNOSE THE PAST, RESEARCH THE PRESENT, REPAIR THE FUTURE Welcome Welcome to the eighteenth edition of ReMEDy. As the saying goes “doesn’t time fly”! the reward of helping to create great One year into my role as Dean of doctors who understand patients and Medicine and I am extremely proud of the world in which we all live, make the milestones the School has achieved these efforts worthwhile. over the last 12 months. We now have This edition’s ‘Making an Impact’ story a fully validated MB BCh programme Finally, my congratulations to highlights the work of Professor Malcolm which is truly innovative and puts Professor Anita Thapar, who recently Mason in defining a standard of care patients at the heart of student learning. won the Ruane Prize for outstanding for locally advanced prostate cancer. Early student feedback fully endorses achievement in the field of child This work has changed medical practice the new programme and welcomes and adolescent psychiatry. I am guidelines in Europe and North America, the opportunity to engage with patients delighted Anita’s passion for child and which will result in the prevention of 43 early on. For many students, this adolescent psychiatry research has per cent of deaths in men with locally approach has helped to consolidate been rewarded in this way and that her advanced prostate cancer.
    [Show full text]
  • Brain & Behavior Research Foundation 30Th Anniversary Celebration
    Brain & Behavior Research Foundation INTERNATIONAL30th Anniversary Celebration AWARDS DINNER FRIDAY, OCTOBER 27th The Pierre 2017 Celebrating our Pardes Humanitarian Prizewinners and Outstanding Achievement Prizewinners WELCOME Welcome to our 2017 International Awards Dinner and our celebration of the 30th anniversary of the Brain & Behavior Research Foundation. This year’s program honors our 2017 Outstanding Achieve- ment Prizewinners, the recipient of the Pardes Humanitarian Prize in Mental Health, and, includes a special Pardes Humanitarian Prize Honorary Tribute to the late Constance E. Lieber, whose leadership as President and President Emeritus of our Foundation, touched so many lives. Connie was one of the world’s greatest public advocates for mental health and psychiatric research and care and she continues to be our guiding light. This year’s Pardes Humanitarian Prize honors Doctors Without Borders/Médecins San Frontières (MSF) for their transformative work in providing mental health care as an integrated component of medical aid during natural and man-made emergencies and chronic crises. Founded in 1971, MSF provides aid in nearly 60 countries and received the 1999 Nobel Peace Prize for its independent, rapid, and fearless work during humanitarian catastrophes. Bestowed annually since 2014, the Pardes Prize recognizes a person(s) or organization whose human- itarian work is transformative and of great magnitude, changing the lives and bringing the joy of living to those facing challenges to mental health. The Prize focuses public attention on the burden of mental illness on individuals and on society, and the urgent need to expand and enhance mental health services both in the developed world and in developing countries.
    [Show full text]
  • Graduate School of Arts and Sciences 2001–2002
    Graduate School of Arts and Sciences Programs and Policies 2001–2002 bulletin of yale university Series 97 Number 10 August 20, 2001 Bulletin of Yale University Postmaster: Send address changes to Bulletin of Yale University, PO Box 208227, New Haven ct 06520-8227 PO Box 208230, New Haven ct 06520-8230 Periodicals postage paid at New Haven, Connecticut Issued sixteen times a year: one time a year in May, October, and November; two times a year in June and September; three times a year in July; six times a year in August Managing Editor: Linda Koch Lorimer Editor: David J. Baker Editorial and Publishing Office: 175 Whitney Avenue, New Haven, Connecticut Publication number (usps 078-500) Printed in Canada The closing date for material in this bulletin was June 10, 2001. The University reserves the right to withdraw or modify the courses of instruction or to change the instructors at any time. ©2001 by Yale University. All rights reserved. The material in this bulletin may not be reproduced, in whole or in part, in any form, whether in print or electronic media, without written permission from Yale University. Graduate School Offices Admissions 432.2773; [email protected] Alumni Relations 432.1942; [email protected] Dean 432.2733; susan.hockfi[email protected] Finance and Administration 432.2739; [email protected] Financial Aid 432.2739; [email protected] General Information Office 432.2770; [email protected] Graduate Career Services 432.2583; [email protected] McDougal Graduate Student Center 432.2583; [email protected] Registrar of Arts and Sciences 432.2330 Teaching Fellow Preparation and Development 432.2583; [email protected] Teaching Fellow Program 432.2757; [email protected] Working at Teaching Program 432.1198; [email protected] Internet: www.yale.edu/gradschool Copies of this publication may be obtained from Graduate School Student Services and Reception Office, Yale University, PO Box 208236, New Haven ct 06520-8236.
    [Show full text]
  • Year in Review
    Year in review For the year ended 31 March 2017 Trustees2 Executive Director YEAR IN REVIEW The Trustees of the Society are the members Dr Julie Maxton of its Council, who are elected by and from Registered address the Fellowship. Council is chaired by the 6 – 9 Carlton House Terrace President of the Society. During 2016/17, London SW1Y 5AG the members of Council were as follows: royalsociety.org President Sir Venki Ramakrishnan Registered Charity Number 207043 Treasurer Professor Anthony Cheetham The Royal Society’s Trustees’ report and Physical Secretary financial statements for the year ended Professor Alexander Halliday 31 March 2017 can be found at: Foreign Secretary royalsociety.org/about-us/funding- Professor Richard Catlow** finances/financial-statements Sir Martyn Poliakoff* Biological Secretary Sir John Skehel Members of Council Professor Gillian Bates** Professor Jean Beggs** Professor Andrea Brand* Sir Keith Burnett Professor Eleanor Campbell** Professor Michael Cates* Professor George Efstathiou Professor Brian Foster Professor Russell Foster** Professor Uta Frith Professor Joanna Haigh Dame Wendy Hall* Dr Hermann Hauser Professor Angela McLean* Dame Georgina Mace* Dame Bridget Ogilvie** Dame Carol Robinson** Dame Nancy Rothwell* Professor Stephen Sparks Professor Ian Stewart Dame Janet Thornton Professor Cheryll Tickle Sir Richard Treisman Professor Simon White * Retired 30 November 2016 ** Appointed 30 November 2016 Cover image Dancing with stars by Imre Potyó, Hungary, capturing the courtship dance of the Danube mayfly (Ephoron virgo). YEAR IN REVIEW 3 Contents President’s foreword .................................. 4 Executive Director’s report .............................. 5 Year in review ...................................... 6 Promoting science and its benefits ...................... 7 Recognising excellence in science ......................21 Supporting outstanding science .....................
    [Show full text]